In Portugal, an increasing trend of carbapenem resistance has been reported by the European Center for Disease Prevention and Control (ECDC) [ 2 ] with an overlapping of multidrug resistance and virulence determinants in KPC-3 K. pneumoniae clinical strains that impose an additional challenge in the treatment of infections caused by this pathogen [ 3 ].
← all excerpts
First Description of Ceftazidime/Avibactam Resistance in a ST13 KPC-70-Producing <i>Klebsiella pneumoniae</i> Strain from Portugal.
1
—
—